Law

J&J Pushed Drug's Sale to Elderly After U.S. Warned of False Safety Claims Johnson & Johnson made plans to reach $302 million in geriatric sales for its antipsychotic Risperdal just months after federal regulators said the company falsely claimed the drug was safe and effective with the elderly, according to internal documents.

Billionaire Blavatnik Said to Seek as Much as 15% Stake of New Lyondell Billionaire Len Blavatnik, who controlled LyondellBasell Industries AF before it went bankrupt, is seeking a 15 percent equity stake in the reorganized company, according to a person with knowledge of the transaction.

Connecticut Says It Will Sue Moody's, S&P Over Subprime Rating Allegations Connecticut Attorney General Richard Blumenthal said he will sue Moody’s Corp. and Standard & Poor’s over allegations tied to credit ratings for subprime loans, according to an e-mailed statement today.

Ex-Deputy Comptroller Loglisci Pleads Guilty in New York Pension Inquiry David Loglisci, a former New York state deputy comptroller, pleaded guilty as part of New York Attorney General Andrew Cuomo’s probe of the state pension fund.

Former Cazenove Partner Calvert Convicted in London of Insider Trading A former partner at JPMorgan Chase & Co.’s Cazenove unit was convicted of insider trading by a London jury, the third such case won by the Financial Services Authority in the last year.

Buyout Funds Can't Spend $503 Billion as Venture Capital Deja Vu Threatens Buyout funds sitting on half a trillion dollars committed by investors may need more than a decade to put the money to work if mergers and acquisitions continue at the current pace.

Bloomberg Law